Activin a Induction of Erythroid Differentiation Sensitizes K562 Chronic Myeloid Leukemia Cells to a Subtoxic Concentration of Imatinib

American Journal of Physiology - Cell Physiology - United States
doi 10.1152/ajpcell.00130.2013
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Physiological Society

Related search

Spred2 Modulates the Erythroid Differentiation Induced by Imatinib in Chronic Myeloid Leukemia Cells

PLoS ONE
Multidisciplinary
2015English

Induction of Apoptosis and Erythroid Differentiation of Human Chronic Myelogenous Leukemia K562 Cells by Low Concentrations of Lidamycin

Oncology Reports
MedicineCancer ResearchOncology
2018English

Global Proteome Quantification for Discovering Imatinib-Induced Perturbation of Multiple Biological Pathways in K562 Human Chronic Myeloid Leukemia Cells

Journal of Proteome Research
BiochemistryChemistry
2010English

Inhibition of the Nrf2-TrxR Axis Sensitizes the Drug-Resistant Chronic Myelogenous Leukemia Cell Line K562/G01 to Imatinib Treatments

2019English

A High Concentration of Triiodothyronine Attenuates the Stimulatory Effect on Hemin-Induced Erythroid Differentiation of Human Erythroleukemia K562 Cells

Endocrine Journal
EndocrinologyMetabolismDiabetes
2015English

Expression of Activin a/Erythroid Differentiation Factor in Murine Bone Marrow Stromal Cells

Blood
BiochemistryImmunologyCell BiologyHematology
1992English

The Development of Imatinib as a Therapeutic Agent for Chronic Myeloid Leukemia

Blood
BiochemistryImmunologyCell BiologyHematology
2005English

ITR‑284 Modulates Cell Differentiation in Human Chronic Myelogenous Leukemia K562 Cells

Oncology Reports
MedicineCancer ResearchOncology
2017English

Therapy of Chronic Myeloid Leukemia: Twilight of the Imatinib Era?

ISRN Oncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy